HIV-infected Rwandan women have a high frequency of long-term survival

AIDS

Volumn 21, Issue SUPPL. 6, 2007, Pages

  Peters, Philip J ^a,f   Karita, Etienne ^c   Kayitenkore, Kayitesi ^c   Meinzen Derr, Jareen ^d   Kim, Dhong Jin ^e   Tichacek, Amanda ^b   Allen, Susan A ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c Projet San Francisco   (Rwanda)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Africa; HIV long term survivors; Natural history; Survival analysis; Survival rate; Women

Indexed keywords

ADULT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MORTALITY; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RWANDA; SEROPREVALENCE; SURVIVAL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; RWANDA; SURVIVAL RATE; VIRAL LOAD;

EID: 36348973469     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000299408.52399.e1     Document Type: Conference Paper

References (32)

1. UNAIDS. AIDS epidemic update: special report on HIV/AIDS. December 2006. Available at: http://www.unaids.org/en/HIV_data/epi2006/default.asp. Accessed: 16 January 2007.
2. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355:1131-1137.
3. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 2000; 181:872-880.
4. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8:1123-1128.
5. The UNAIDS Reference Group on Estimates MaP. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS 2002; 16:W1-W14.
6. Deschamps MM, Fitzgerald DW, Pape JW, Johnson WD Jr. HIV infection in Haiti: natural history and disease progression. AIDS 2000; 14:2515-2521.
7. Rangsin R, Chiu J, Khamboonruang C, Sirisopana N, Eiumtrakul S, Brown AE, et al. The natural history of HIV-1 infection in young Thai men after seroconversion. J Acquir Immune Defic Syndr 2004; 36:622-629.
8. Anzala OA, Nagelkerke NJ, Bwayo JJ, Holton D, Moses S, Ngugi EN, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-689.
9. Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16:597-603.
10. Glynn JR, Sonnenberg P, Nelson G, Bester A, Shearer S, Murray J. Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up. AIDS 2007; 21:625-632.
11. Allen S, Lindan C, Serufilira A, Van de Perre P, Rundle AC, Nsengumuremyi F, et al. Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA 1991; 266:1657-1663.
12. Allen S, Serufilira A, Bogaerts J, Van de Perre P, Nsengumuremyi F, Lindan C, et al. Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA 1992; 268:3338-3343.
13. Allen S, Van de Perre P, Serufilira A, Lepage P, Carael M, DeClercq A, et al. Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis 1991; 164:67-71.
14. Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A, et al. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992; 116:320-328.
15. Lifson AR, Allen S, Wolf W, Serufilira A, Kantarama G, Lindan CP, et al. Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization HIV staging system and recommended modifications. Ann Intern Med 1995; 122:262-270.
16. Ramlau-Hansen H. Smoothing counting process intensities by means of kernel functions. Ann Stat 1983; 11:453-466.
17. Koblin BA, van Benthem BH, Buchbinder SP, Ren L, Vittinghoff E, Stevens CE, et al. Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995. Am J Epidemiol 1999; 150:1026-1030.
18. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179:68-73.
19. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185:1244-1250.
20. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843-852.
21. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007; 195:1177-1180.
22. Fischer A, Lejczak C, Lambert C, Roman F, Servais J, Karita E, et al. Is the Vpr R77Q mutation associated with long-term nonprogression of HIV infection? AIDS 2004; 18:1346-1347.
23. Lazaryan A, Lobashevsky E, Mulenga J, Karita E, Allen S, Tang J, Kaslow RA. Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol 2006; 80:6056-6060.
24. Costello C, Tang J, Rivers C, Karita E, Meizen-Derr J, Allen S, Kaslow RA. HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS 1999; 13:1990-1991.
25. Tang J, Rivers C, Karita E, Costello C, Allen S, Fultz PN, et al. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes Immun 1999; 1:20-27.
26. Masquelier C, Servais JY, Rusanganwa E, Roman F, Havuga E, Servais J, et al. A novel 24-base pair deletion in the coding region of CCR5 in an African population. AIDS 2007; 21:111-113.
27. Mikhail M, Wang B, Saksena NK. Mechanisms involved in nonprogressive HIV disease. AIDS Rev 2003; 5:230-244.
28. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses 1996; 12:585-592.
29. Rwandan HIV Seroprevalence Study Group. Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a central African country. Lancet 1989; 1:941-943.
30. Allen S, Serufilira A, Gruber V, Kegeles S, Van de Perre P, Carael M, Coates TJ. Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health 1993; 83:705-710.
31. Glynn JR, Buve A, Carael M, Kahindo M, Macauley IB, Musonda RM, et al. Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. J Acquir Immune Defic Syndr 2000; 25:345-352.
32. Fabiani M, Nattabi B, Ayella EO, Ogwang M, Declich S. Differences in fertility by HIV serostatus and adjusted HIV prevalence data from an antenatal clinic in northern Uganda. Trop Med Int Health 2006; 11:182-187.